FFAR2 and obesity disorder: In addition to the reduction in obesogenic diet-induced hypertrophy of both SAT and VAT when FFA2 is absent in the intestine, WD-fed Vil-FFA2 were significantly protected from obesity during the first half of the study, and this effect diminished after 14–16 weeks of dietary intervention.